Envoy Medical, Inc.COCH

Key ratios

FCF / Sales

-10488.0%TTM

2025 -7626.3%2024 -8412.4%2023 -5456.8%

ROA

-86.5%TTM

2025 -137.3%2024 -121.5%2023 -212.0%

Revenue growth

-6.8%TTM

2025 7.1%2024 -28.8%2023 33.3%

Recent news

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones 2026-08-10 · Newsfile

Track COCH in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer